查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1673021

生命科學 BPO 市場：按服務類型、最終用戶和地區分類

Life Sciences BPO Market, By Service Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球生命科學 BPO 市場規模預估為 4,628.3 億美元，預計到 2032 年將達到 1,1168.1 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 13.4%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 4628.3億美元
效能資料 2020-2024 預測期 2025-2032
預測期：2025 年至 2032 年複合年成長率 13.40％ 2032 年金額預測 11,168.10億美元
數字。生命科學 BPO 市場區域佔有率（%）（2025 年）
生命科學 BPO 市場-IMG1

生命科學 BPO 市場是向醫療保健產業提供的外包服務，包括製藥、生技和醫療設備公司。我們幫助生命科學公司專注於其核心業務：藥物發現、產品開發和商業化。監管事務管理、臨床資料管理、醫學寫作、出版、藥物安全檢測、醫療監測和其他臨床測試相關服務外包給專業的 BPO 提供者。成本最佳化、獲得先進基礎設施和專業知識、複雜的法律規範以及簡化業務的需求等因素正在推動生命科學領域外包的增加。

市場動態

全球生命科學 BPO 市場的成長是由生命科學公司對成本最佳化的不斷成長的需求，以及獲得 BPO服務供應商提供的先進基礎設施和專業知識的好處所驅動。此外，藥物開發和核准的法律規範每年都變得越來越複雜，因此有必要將非核心功能外包。此外，醫療保健產業的變化動態，例如向價值驅動型醫療保健的轉變，也正在推動生命科學公司透過策略性外包來簡化業務。然而，資料安全問題、對關鍵功能的控制喪失以及與供應商管理相關的營運挑戰等因素可能會阻礙市場成長。新興市場的醫療保健支出、生物相似藥和基因組藥物的開發以及人工智慧/區塊鏈的整合以增強 BPO 服務可能為市場成長提供機會。

研究的主要特點

本報告對全球生命科學 BPO 市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模（以十億美元計）和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球生命科學 BPO 市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。

研究涉及的主要企業包括 Cognizant、埃森哲、Genpact、EXL services、Catalent 等。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球生命科學 BPO 市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過全球生命科學 BPO 市場分析中使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 一致的機會圖 (COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管情景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章 全球生命科學 BPO 市場-COVID-19 疫情的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020 年至 2032 年按服務類型分類的全球生命科學 BPO 市場（十億美元）

  • 介紹
  • 醫藥外包
  • 翻譯
  • 成品劑型
  • 包裝
  • 藥物研發
  • 臨床前研究
  • 臨床實驗室研究
  • 監管服務
  • 藥品安全監控
  • 醫療設備外包
  • 電子製造服務
  • 成品
  • 原料及零件
  • 監理諮詢服務
  • 產品設計與開發服務
  • 產品測試服務
  • 產品實施服務
  • 產品升級服務
  • 產品維護服務
  • 合約銷售和市場外包
  • 其他

6. 2020 年至 2032 年全球生命科學 BPO 市場（以最終用戶分類）（十億美元）

  • 介紹
  • 製藥公司
  • 生技公司
  • 合約研究組織
  • 醫療設備公司
  • 學術和政府機構

7. 2020 年至 2032 年全球生命科學 BPO 市場（按地區分類）（單位：十億美元）

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭格局

  • 公司簡介
    • Accenture, Plc
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab BIoTechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

第 9 章分析師建議

  • 興衰
  • 一致的機會地圖

第10章參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI24

Global Life Sciences Bpo Market is estimated to be valued at USD 462.83 Bn in 2025 and is expected to reach USD 1,116.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 462.83 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.40% 2032 Value Projection: USD 1,116.81 Bn
Figure. Life Sciences Bpo Market Share (%), By Region 2025
Life Sciences BPO Market - IMG1

The life sciences BPO market comprises outsourcing services provided to pharmaceutical, biotechnology, medical device companies and others in the healthcare industry. It helps life sciences companies to focus on core activities of drug discovery, product development and commercialization. Services like regulatory affairs management, clinical data management, medical writing and publishing, pharmacovigilance, medical monitoring and other clinical trial related services are outsourced to specialized BPO players. Factors such as cost optimization, access to advanced infrastructure and expertise, complex regulatory frameworks and need to streamline operations has increased outsourcing in the life sciences sector.

Market Dynamics:

Global life sciences BPO market growth is driven by rising need for cost-optimization among life sciences companies coupled with benefits of access to advanced infrastructure and expertise delivered by BPO service providers. Moreover, regulatory frameworks for drug development and approval have become highly complex over the years, thus, necessitating outsourcing of non-core functionalities. Changing dynamics of the healthcare industry including shift towards value-based care has also prompted life sciences players to streamline their operations through strategic outsourcing. However, factors such as data security concerns, loss of control over critical functions and operational challenges associated with vendor management can hamper the market growth. Growing healthcare expenditure in developing regions, development of biosimilars & genomic drugs and integration of AI/blockchain to enhance BPO services can offer market growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global life sciences BPO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global life sciences BPO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Cognizant, Accenture, Genpact, EXL services, and Catalent

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global life sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life sciences BPO market

Detailed Segmentation-

  • By Service Type
    • Pharmaceutical outsourcing
    • Contract manufacturing market
    • API
    • Finished dose form
    • Packaging
    • Contract research organizations
    • Drug discovery
    • Preclinical studies
    • Clinical trial studies
    • Regulatory services
    • Pharmacovigilance
    • Medical devices outsourcing
    • Contract manufacturing market
    • Electronic manufacturing services
    • Finished goods
    • Raw materials/components
    • Contract research organizations
    • Regulatory consulting services
    • Product design and development services
    • Product testing services
    • Product implementation services
    • Product upgrade services
    • Product maintenance services
    • Contract sales & market outsourcing
    • Others
  • By End User
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organizations Medical Device Companies
    • Academic Institutes & Government Organizations
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Accenture, Plc
    • Boehringer Ingelheim GmbH
    • Cognizant Technology Solutions
    • Infosys
    • Genpact Limited
    • ProMab Biotechnologies, Inc
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Life Sciences BPO Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Life Sciences BPO Market, By Service Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pharmaceutical outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Contract manufacturing market
  • API
  • Finished dose form
  • Packaging
    • Contract research organizations
  • Drug discovery
  • Preclinical studies
  • Clinical trial studies
  • Regulatory services
  • Pharmacovigilance
  • Medical devices outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Contract manufacturing market
  • Electronic manufacturing services
  • Finished goods
  • Raw materials/components
    • Contract research organizations
  • Regulatory consulting services
  • Product design and development services
  • Product testing services
  • Product implementation services
  • Product upgrade services
  • Product maintenance services
  • Contract sales & market outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Life Sciences BPO Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medical Device Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic Institutes & Government Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Life Sciences BPO Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Accenture, Plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim GmbH
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cognizant Technology Solutions
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Infosys
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Genpact Limited
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ProMab Biotechnologies, Inc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Charles River Laboratories International, Inc
    • Catalent, Inc.
    • Covance, Inc.
    • Fareva
    • ICON, Plc
    • DSM
    • Health Decisions, Inc.
    • IQVIA
    • Laboratory Corporation of America Holdings
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact